Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results
... income in the second quarter was $411 million, versus $499 million in the second quarter of last year. ... second quarter net income was $620 million, versus $351 million in the second quarter of last year. ... net income was approximately $1.1 billion, versus net income of $601 million in the same period ...Hill-Rom Reports Third Quarter Financial Results
... Revenue of $335 million declined 8.8 percent versus prior year and was stable to last quarter ... share from continuing operations were $0.25 versus $0.34 in prior year (which included $0.12 in ... flow was $61 million, an increase of $58 million versus prior year Cash position up $44 ...Smart Balance Announces 2009 Second Quarter Results
... net sales of $58.2 million, an increase of 21.2% versus year ago, and earnings per share of $0.02, versus a loss of $0.02 per share in 2008. The second quarter net sales increase versus 2008 was due to a 13% volume growth in case ...SXC Health solutions announces record second quarter financial results
... 2009: - Revenue of $1.35-$1.4 billion versus prior estimate of $1.25-$1.35 billion - Gross profit of $166-$171 million versus prior estimate of $145-$155 million - ... amortization) of $1.42-$1.50 versus prior estimate of $0.93-$1.01 - Adjusted ...Clarient Reports Second Quarter Revenue Up 40 Percent
... in revenue for the second quarter of 2009 versus the second quarter of 2008, and a 43 percent increase in revenue for this year's first six months versus the first six months of 2008. Second ... June 30, 2009, operating income was $2.3 million versus an operating loss of $1.9 million for the six ...Innophos Holdings, Inc. Reports Second Quarter 2009 Results
... million, a decrease of $58.6 million, or 65.1%, versus $90.0 million for the comparable period in 2008. ... was $3.6 million, a decrease of $4.8 million versus $8.4 million for the comparable period in 2008. ... was $10.7 million, a decrease of $12.0 million versus $22.7 million for the comparable period in 2008. ...5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
... of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in ... controlled study with insulin glargine versus NPH human insulin ," said lead investigator ... the retinal safety profile of Lantus(R) versus NPH in 1024 patients (Lantus(R) once daily: 515 ...New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
... prebiotics had an 80% survival rate to 24 months versus a 50% survival rate for the control group rats ... reductions in cholesterol and body weight versus the control group. Significantly, the ... has repeatedly shown synergistic health benefits versus the more common single-prebiotic fibers such as ...Ocuvite® Extra Eye Vitamin and Mineral Supplements
Description:... offer everything that is in Ocuvite® original formula plus more. Ocuvite Extra contains 2 mg of lutein and higher levels of vitamins C versus the original formula. Ocuvite Extra also contains other antioxidants and minerals traditionally found in multivitamins such as Vitamins A, ...Sonoclot Coagulation & Platelet Function Analyzer
Description:... or plasma. It is used worldwide to manage anticoagulant therapy, assess platelet function, control blood product usage, differentiate mechanical versus hemostatic bleeders, identify hypercoagulable and heparin resistant patients, and screen for hyperfibrinolysis. Clinical areas include open heart ...PosiBlot 30-30 Pressure Blotter and Pressure Control Station - 120V
Description:... high pressure to be applied to gel Part of an integrated system allowing electrophoresis, gel treatment, transfer and UV crosslinking in 2.5 hours, versus 29 hours required for conventional methods Positive pressure drives buffer through gel Reduces problem of gel collapse associated with vacuum ...Single thawed embryo transfer after PGD does not affect pregnancy rates
... similar between the PGD and IVF/ICSI groups (87% versus 88% respectively). There was no significant ... implantation and clinical pregnancy rates (35% versus 29% and 34% versus 36% respectively). The overall ongoing pregnancy ...Study shows CGM devices also benefit people with type 1 diabetes
... an improvement in HbA1c of more than 0.3% (31% versus 5% in the control group) fewer had a worsening of HbA1c greater than 0.3% (28% versus 52%) more CGM users had a HbA1c level below 7% at 26 weeks (88% versus 63%) more people in the CGM group than the ...February 2009 Geology and GSA Today media highlights
... about Mars; continuation of the "jelly sandwich" versus "crme brle" debate; support for the Snowball ... plumes). The conditions required for diapir versus cavity plume generation are different, and in a ... a weak lithosphere mantle, e.g. "jelly sandwich" versus "crme brle," respectively. In the study by ...2009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
... an attack upon it. This effect, called Graft versus Host disease, leads to severe tissue and organ ... and can result in death. Prevention of Graft versus Host disease has long evaded scientists, despite ... Notch activity is a driving force behind Graft versus Host disease. Moreover, as Notch activity is ...Proactive care saves lives of seniors, study finds
... CMP patients died in the first year of enrollment versus 9.2 percent of control patients; 13.1 percent of ... group they were significantly lower 21.2 percent versus 25.7 percent for controls at one year and 30.5 percent versus 39.2 percent for controls at two years. ...Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
... test-of-cure visit was 82.2 percent for iclaprim versus 85.3 percent for linezolid in the intent-to-treat ... were: gastrointestinal disorders (7.4 percent versus 10.4 percent for iclaprim and linezolid, ... and administration site conditions (4.2 percent versus 3.9 percent); nervous system disorders (4.8 ...SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
... net loss per share was 61,137,755 for this period versus 47,146,856 for the second quarter of 2008. ... the first six months of 2009 were $55.9 million, versus $41.2 million for the comparable period in 2008. ... loss per share was 61,078,534 for this period versus 46,238,618 for the first half of 2008. ...Sanofi-aventis Announces Second Quarter 2009 Results
... the first half of 2009 was euro 2,637 million, versus euro 2,335 million for the first half of 2008. ... the results of a 5-year study of Lantus ((R)) versus NPH insulin on progression of retinopathy in ... and general expenses to net sales was 24.9% versus 26.2% for the first half of 2008, thanks to the ...NeoGenomics Reports Second Quarter 2009 Results
... Highlights: Revenue increased 53% versus Q2 08 to $7.5 million Revenue increased ... performed. Average revenue per test was flat versus last quarter. Gross profit margin remained ... controlled and decreased by 5% or $126,000 versus Q1 09. Total SG&A expenses as a percentage ...Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... percent in the corifollitropin alfa treatment arm versus 1.6 percent in the rFSH treatment group.(5) ... the corifollitropin alfa group was 13.3 (+/-7.3) versus 10.6 (+/-5.9) in the reference group.(5) ... Behr B, et al Corifollitropin alfa versus recombinant FSH treatment in controlled ovarian ...Phase 3 Cystic Fibrosis Trial Results Presented at European Conference
... for the 26 weeks was lower for Bronchitol versus control: overall reduction in rate of 25% ... compared with placebo, included cough (25.4% versus 20.3%), haemoptysis (11.9% versus 8.5%) and pharyngolaryngeal pain ...Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Description:... with rat (100%), mouse (78%), bovine (74%) and guinea pig (48%). Slight reactivity with human (31%). Specificity confirmed by Western blot versus bovine Gat, rat Goa, rat Gia-1, Gia-2, rat Gia-3, bovine Gsa, and murine GoaA and ....Glycoprotein Isolation Kit WGA from Pierce Biotechnology, Inc.
Description:... lectin, selectively binds to N-Acetyl glucosamine (GlcNAc) groups and to sialic acid. High recovery Equivalent or greater glycoprotein recovery versus competitor kits and lectin resins Fast Glycoprotein purification in less than an hour Versatile Isolate glycoproteins from various sample ...HEEBO Human Genome Set 200 pmol from Invitrogen
Description:... patterns, and as broadly as possible, alternative splicing. An exon-centric design allows the differentiation of constitutively expressed versus alternatively expressed exons. This design also supports comparative genome hybridization (CGH) analysis. In addition to the exon-centric probes, the ...Rotarod Treadmill one unit for mice and rats from IITC Life Science
Description:... be printed automatically along with test parameters entered. • Animals drop is sensed by accurate magnetic switches that never need adjusting versus other units on the market today which use photoelectric sensing. Vertically sliding acrylic front gates prevent escape of animals • The ...UltraPure Agarose and SYBR Safe DNA Gel Stain combo from Invitrogen
Description:... UltraPure Agarose and SYBR Safe DNA Gel Stain combo offers these benefits: Saves money versus buying these same products separately Offers a safer and better alternative to ethidium bromide Eliminates risks to yourself, the ...UltraPure Agarose and SYBR Safe DNA Gel Stain Combo from Invitrogen
Description:... UltraPure Agarose and SYBR Safe DNA Gel Stain combo offers these benefits: Saves money versus buying these same products separately Offers a safer and better alternative to ethidium bromide Eliminates risks to yourself, the ...